Vera Therapeutics, Inc. Capital Expenditures
Vera Therapeutics, Inc. (VERA) reported Capital Expenditures of $23.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $23.00K, a 87.70% decline year-over-year.
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $102.00K, a 84.19% decline year-over-year.
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $133.00K, a 44.12% decline year-over-year.
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $630.00K, a 35.19% decline from fiscal 2024.
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $972.00K, a 1442.86% increase from fiscal 2023.
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $63.00K, a 1.61% increase from fiscal 2022.
- Vera Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $62.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $23.00K 10-Q · filed 2026-08-10 | $125.00K derived: sum of 3 quarters · filed 2026-08-10 | $258.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $23.00K 10-Q · filed 2026-05-07 | $125.00K derived: sum of 2 quarters · filed 2026-05-07 | $258.00K derived: sum of 3 quarters · filed 2026-05-07 | $466.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $235.00K derived: sum of 2 quarters · filed 2026-02-26 | $443.00K derived: sum of 3 quarters · filed 2026-08-10 | $630.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $341.00K derived: sum of 2 quarters · filed 2026-08-10 | $528.00K 10-Q · filed 2025-11-05 | $1.17M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $395.00K 10-Q · filed 2026-08-10 | $1.04M derived: sum of 3 quarters · filed 2026-08-10 | $1.28M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $187.00K 10-Q · filed 2026-05-07 | $832.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.07M derived: sum of 3 quarters · filed 2026-05-07 | $1.16M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $883.00K derived: sum of 2 quarters · filed 2026-02-26 | $972.00K derived: sum of 3 quarters · filed 2026-02-26 | $972.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $327.00K derived: sum of 2 quarters · filed 2025-11-05 | $327.00K 10-Q · filed 2025-11-05 | $390.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $89.00K 10-Q · filed 2025-08-05 | $152.00K derived: sum of 3 quarters · filed 2026-02-26 | $152.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | $63.00K derived: sum of 2 quarters · filed 2026-02-26 | $63.00K derived: sum of 3 quarters · filed 2026-02-26 | $63.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $63.00K derived: sum of 2 quarters · filed 2026-02-26 | $63.00K derived: sum of 3 quarters · filed 2026-02-26 | $63.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-08 | $38.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-27 | $38.00K derived: sum of 3 quarters · filed 2024-03-27 | $44.00K derived: sum of 4 quarters · filed 2024-03-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $38.00K derived: sum of 2 quarters · filed 2024-03-27 | $44.00K derived: sum of 3 quarters · filed 2024-03-27 | $62.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $44.00K derived: sum of 2 quarters · filed 2023-11-09 | $62.00K 10-Q · filed 2023-11-09 | $62.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $24.00K 10-Q · filed 2023-08-10 | $24.00K derived: sum of 3 quarters · filed 2023-08-10 | $24.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $18.00K 10-Q · filed 2023-05-11 | $18.00K derived: sum of 2 quarters · filed 2023-05-11 | $18.00K derived: sum of 3 quarters · filed 2023-05-11 | $18.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | $0.00 derived: sum of 3 quarters · filed 2022-08-10 | $0.00 derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $0.00 derived: sum of 3 quarters · filed 2022-05-16 | $47.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $47.00K derived: sum of 3 quarters · filed 2022-03-28 | $99.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $47.00K derived: sum of 2 quarters · filed 2021-11-10 | $99.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $99.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $52.00K 10-Q · filed 2021-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |